Maintenance acne therapy: prophylactic efficacy of fixed combination of adapalene and benzoyl peroxide
https://doi.org/10.33667/2078-5631-2020-24-57-62
Abstract
Acne is a chronic disease and even reliable therapies do not completely ensure absence of relapses. Acne relapses have a negative psychological impact on patients, as they feel unable to control the disease and achieve complete and long-lasting recovery. Supportive therapy is necessary to prolong the remission of acne achieved with initial successful treatment and to minimize the risk of relapse. According to the literature sources, the most justified as a maintenance therapy is the use of topical retinoids, which have been shown to be effective in the prevention of exacerbations of acne. In the present study 54 patients were involved who after the active therapy used a fixed combination of adapalene 0.1% / BPO 2.5% as maintenance treatment. Only 1 patient (2.9%) with moderate acne and 2 patients (5.8%) with severe acne had a relapse within 6 months of maintenance therapy. The absence of adverse events during the course of treatment was recorded, as well as high adherence of patients to the treatment. During the period of post-treatment observation (6 months after maintenance therapy), among the patients without exacerbations during maintenance therapy, a relapse occurred in 2 (7.1%) patients of group 1 (n = 28) and 2 (8.7%) patients of group 2 (n = 23). The obtained data indicates that maintenance therapy with Effezel® gel can extend the achieved effectiveness of the treatment and prevent the development of relapses.
About the Authors
L. S. Kruglova
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Moscow
Russian Federation
Moscow
N. V. Gryazeva
Central State Medical Academy of the Administrative Department of the President of Russia
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr. Global Alliance to Improve Outcomes in Acne: New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60 (5 suppl): S1–S50.
2. Zane L. Acne maintenance therapy: expanding the role of topical retinoids? Arch Dermatol 2006; 142: 638–640.
3. Thielitz A, Helmdach M, Röpke EM, Gollnick H. Lipid analysis of follicular casts from cyanoacrylate strips as a new method for studying therapeutic effects of antiacne agents. Br J Dermatol 2001; 145: 19–27.
4. Schmidt N, Gans EH. Tretinoin: a review of its anti-inflammatory properties in the treatment of acne. J Clin Aesthet Dermatol 2011; 4: 22–29.
5. Kang S. The mechanism of action of topical retinoids. Cutis 2005; 75: 10–13.
6. Gollnick H, Cunliffe WJ, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Global Alliance to Improve Outcomes in Acne: Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003; 49 (1 suppl): S1–S37.
7. Cunliffe W, Gollnick H. Acne – Diagnosis and Management. London, Martin Dunitz, 2001. Journal of the Royal Society of Medicine 94 (12): 652–652.
8. Zouboulis CC. The truth behind this undeniable efficacy – recurrence rates and relapse risk factors of acne treatment with oral isotretinoin. Dermatology 2006; 212: 99–100.
9. Zhang JZ, Li LF, Tu YT, Zheng JJ. A successful maintenance approach in inflammatory acne with adapalene gel 0.1% after an initial treatment in combination with clindamycin topical solution 1% or after monotherapy with clindamycin topical solution 1%. J Dermatolog Treat 2004; 15: 372–378.
10. Thielitz A, Sidou F, Gollnick H. Control of microcomedone formation throughout a maintenance treatment with adapalene gel, 0.1%. J Eur Acad Dermatol Venereol. 2007; 21: 747–753.
11. Thiboutot DM, Shalita AR, Yamauchi PS, Dawson C, Kerrouche N, Arsonnaud S, Kang S. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol. 2006; 142: 597–602.
12. Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Kerrouche N, Sidou F, Soto P. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol. 2007; 17: 45–51.
13. Cassano N, Amoruso A, Alessandrini G, Biuso A, Carrieri G, Fai D, Gabellone M, Ligori P, Malvindi C, Mancino A. Treatment of inflammatory acne with a combination therapy with lymecycline and adapalene followed by maintenance treatment with adapalene. Eur J Inflamm. 2004; 2: 45–52.
14. Leyden J, Thiboutot DM, Shalita AR, Webster G, Washenik K, Strober BE, Shupack J. Comparison of tazarotene and minocycline maintenance therapies in acne vulgaris: a multicenter, double-blind, randomized, parallel group study. Arch Dermatol. 2006; 142: 605–612.
15. Vender R, Vender R. Double-blinded, vehicle-controlled proof of concept study to investigate the recurrence of inflammatory and noninflammatory acne lesions using tretinoin gel (microsphere) 0.04% in male patients after oral isotretinoin use. Dermatol Res Pract. Volume 2012 Article ID736532.
16. Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol 2001; 11: 538–544.
17. Poulin Y, Sanchez NP, Bucko A, Fowler J, Jarratt M, Kempers S, Kerrouche N, Dhuin JC, Kunynetz R. A 6-month maintenance therapy with adapalene-benzoyl peroxide gel prevents relapse and continuously improves efficacy among patients with severe acne vulgaris: results of a randomized controlled trial. Br J Dermatol 2011; 164: 1376–1382.
18. Bettoli V, Mantovani L, Borghi A. Adapalene 0.1% cream after oral isotretinoin: evaluation of acne recurrence incidence. Rhodes: Medimond Monduzzi Editore International Proceedings, Division 15th Congress of the European Academy of Dermatology and Venereology, 2006; 212: 206–715.
19. Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol 2011; 25: 1094–1098.
Review
For citations:
Kruglova L.S., Gryazeva N.V. Maintenance acne therapy: prophylactic efficacy of fixed combination of adapalene and benzoyl peroxide. Medical alphabet. 2020;(24):57-62. (In Russ.) https://doi.org/10.33667/2078-5631-2020-24-57-62
Views:
1560
Email this article 